ClariVest Asset Management’s Cullinan Oncology CGEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $453 | Hold |
26
| – | – | ﹤0.01% | 793 |
|
|
2024
Q2 | $453 | Sell |
26
-60
| -70% | -$1.05K | ﹤0.01% | 793 |
|
|
2024
Q1 | $1.47K | Buy |
86
+32
| +59% | +$545 | ﹤0.01% | 615 |
|
|
2023
Q4 | $550 | Hold |
54
| – | – | ﹤0.01% | 804 |
|
|
2023
Q3 | $0 | Hold |
54
| – | – | ﹤0.01% | 767 |
|
|
2023
Q2 | $1K | Hold |
54
| – | – | ﹤0.01% | 585 |
|
|
2023
Q1 | $1K | Hold |
54
| – | – | ﹤0.01% | 624 |
|
|
2022
Q4 | $1K | Buy |
54
+25
| +86% | +$463 | ﹤0.01% | 600 |
|
|
2022
Q3 | $0 | Hold |
29
| – | – | ﹤0.01% | 693 |
|
|
2022
Q2 | $0 | Sell |
29
-30
| -51% | – | ﹤0.01% | 695 |
|
|
2022
Q1 | $0 | Hold |
59
| – | – | ﹤0.01% | 733 |
|
|
2021
Q4 | $0 | Hold |
59
| – | – | ﹤0.01% | 759 |
|
|
2021
Q3 | $2K | Hold |
59
| – | – | ﹤0.01% | 620 |
|
|
2021
Q2 | $2K | Buy |
+59
| New | +$2K | ﹤0.01% | 608 |
|